Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012 (2012), Article ID 986265, 9 pages
http://dx.doi.org/10.1155/2012/986265
Research Article

Formulation Strategies, Characterization, and In Vitro Evaluation of Lecithin-Based Nanoparticles for siRNA Delivery

1Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Junín 954 1113AAD Buenos Aires, Argentina
2Institute of Biochemistry and Biophysics (IQUIFIB), National Science Research Council (CONICET), Junín 954 1113AAD Buenos Aires, Argentina

Received 14 October 2011; Revised 22 December 2011; Accepted 16 January 2012

Academic Editor: Fabiana Quaglia

Copyright © 2012 Sebastián Ezequiel Pérez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, and C. C. Mello, “Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans,” Nature, vol. 391, no. 6669, pp. 806–811, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. G. J. Hannon, “RNA interference,” Nature, vol. 418, no. 6894, pp. 244–251, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. N. J. Caplen, “RNAi as a gene therapy approach,” Expert Opinion on Biological Therapy, vol. 3, no. 4, pp. 575–586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Matranga, Y. Tomari, C. Shin, D. P. Bartel, and P. D. Zamore, “Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes,” Cell, vol. 123, no. 4, pp. 607–620, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. de Fougerolles, H. P. Vornlocher, J. Maraganore, and J. Lieberman, “Interfering with disease: a progress report on siRNA-based therapeutics,” Nature Reviews Drug Discovery, vol. 6, no. 6, pp. 443–453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Ozpolat, A. K. Sood, and G. Lopez-Berestein, “Nanomedicine based approaches for the delivery of siRNA in cancer,” Journal of Internal Medicine, vol. 267, no. 1, pp. 44–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Li and F. C. Szoka, “Lipid-based nanoparticles for nucleic acid delivery,” Pharmaceutical Research, vol. 24, no. 3, pp. 438–449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Zou, K. Scarfo, M. H. Nantz, and J. G. Hecker, “Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells,” International Journal of Pharmaceutics, vol. 389, no. 1-2, pp. 232–243, 2010. View at Publisher · View at Google Scholar
  9. B. Geusens, J. Lambert, S. C. De Smedt, K. Buyens, N. N. Sanders, and M. Van Gele, “Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes,” Journal of Controlled Release, vol. 133, no. 3, pp. 214–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Nishikawa and L. Huang, “Nonviral vectors in the new millennium: delivery barriers in gene transfer,” Human Gene Therapy, vol. 12, no. 8, pp. 861–870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. W. F. Anderson, “Human gene therapy,” Nature, vol. 392, no. 6679, pp. 25–30, 1998. View at Google Scholar · View at Scopus
  12. B. Khurana, A. K. Goyal, A. Budhiraja, D. Arora, and S. P. Vyas, “siRNA delivery using nanocarriers—an efficient tool for gene silencing,” Current Gene Therapy, vol. 10, no. 2, pp. 139–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Weyermann, D. Lochmann, and A. Zimmer, “Comparison of antisense oligonucleotide drug delivery systems,” Journal of Controlled Release, vol. 100, no. 3, pp. 411–423, 2004. View at Publisher · View at Google Scholar
  14. P. Midoux, C. Pichon, J. J. Yaouanc, and P. A. Jaffrès, “Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers,” British Journal of Pharmacology, vol. 157, no. 2, pp. 166–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. L. Lemke, “Pharmaceutical biotechnology: from nucleic acids to personalized medicine,” in Foye's Principles of Medicinal Chemistry, pp. 115–175, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 6th edition, 2008. View at Google Scholar
  16. S. Dokka, D. Toledo, X. Shi, V. Castranova, and Y. Rojanasakul, “Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes,” Pharmaceutical Research, vol. 17, no. 5, pp. 521–525, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Spagnou, A. D. Miller, and M. Keller, “Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA,” Biochemistry, vol. 43, no. 42, pp. 13348–13356, 2004. View at Google Scholar · View at Scopus
  18. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan, “Toxicity of cationic lipids and cationic polymers in gene delivery,” Journal of Controlled Release, vol. 114, no. 1, pp. 100–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. N. Landen, A. Chavez-Reyes, C. Bucana et al., “Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery,” Cancer Research, vol. 65, no. 15, pp. 6910–6918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Halder, A. A. Kamat, C. N. Landen et al., “Focal adhesion kinasetargeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy,” Clinical Cancer Research, vol. 12, no. 16, pp. 4916–4924, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Gray, G. Van Buren, N. A. Dallas et al., “Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver,” Journal of the National Cancer Institute, vol. 100, no. 2, pp. 109–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. W. M. Merritt, Y. G. Lin, W. A. Spannuth et al., “Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth,” Journal of the National Cancer Institute, vol. 100, no. 5, pp. 359–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Gewirtz, “On future's doorstep: RNA interference and the pharmacopeia of tomorrow,” Journal of Clinical Investigation, vol. 117, no. 12, pp. 3612–3614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sznitowska, E. A. Dabrowska, and S. Janicki, “Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin,” International Journal of Pharmaceutics, vol. 246, no. 1-2, pp. 203–206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Cui, F. Qiu, and B. R. Sloat, “Lecithin-based cationic nanoparticles as a potential DNA delivery system,” International Journal of Pharmaceutics, vol. 313, no. 1-2, pp. 206–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sznitowska, M. Klunder, and M. Placzek, “Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin,” Chemical and Pharmaceutical Bulletin, vol. 56, no. 1, pp. 70–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Bañez-Coronel, A. Ramírez De Molina, A. Rodríguez-González et al., “Choline kinase alpha depletion selectively kills tumoral cells,” Current Cancer Drug Targets, vol. 8, no. 8, pp. 709–719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Ackerstaff, K. Glunde, and Z. M. Bhujwalla, “Choline phospholipid metabolism: a target in cancer cells?” Journal of Cellular Biochemistry, vol. 90, no. 3, pp. 525–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Walter, G. Kuehl, K. Barnes, and G. VanderWaerdt, “The vesicle-to-micelle transition of phosphatidylcholine vesicles induced by nonionic detergents: effects of sodium chloride, sucrose and urea,” Biochimica et Biophysica Acta, vol. 1508, no. 1-2, pp. 20–33, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. X. Huang, “Laser light scattering studies on thermodynamics of C8-lecithin and monovalent salt solutions,” Journal of Chemical Physics, vol. 107, no. 21, pp. 9141–9145, 1997. View at Google Scholar · View at Scopus
  31. J. M. Barichello, S. Kizuki, T. Tagami et al., “Agitation during lipoplex formation improves the gene knockdown effect of siRNA,” International Journal of Pharmaceutics, vol. 410, no. 1-2, pp. 153–160, 2011. View at Publisher · View at Google Scholar
  32. M. Silvander, G. Karlsson, and K. Edwards, “Vesicle solubilization by alkyl sulfate surfactants: a cryo-TEM study of the vesicle to micelle transition,” Journal of Colloid and Interface Science, vol. 179, no. 1, pp. 104–113, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. X. Huang, R. C. Tan, Y. L. Li, Y. Q. Yang, L. Yu, and Q. C. He, “Effect of salts on the formation of C8-lecithin micelles in aqueous solution,” Journal of Colloid and Interface Science, vol. 236, no. 1, pp. 28–34, 2001. View at Publisher · View at Google Scholar · View at Scopus